HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Research Dictionary Pharma Mobile

Sign Up FREE or Login

Hair Diseases

Subscribe to New Research on Hair Diseases

Diseases affecting the orderly growth and persistence of hair.

Also Known As:

Hair Disease

Networked: 18 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Disease Context: Research Results

Skin and Connective Tissue Diseases
- Skin Diseases: 8226
  - Hair Diseases: 18

Related Diseases

1.	Monilethrix
2.	Xeroderma Pigmentosum (Kaposi's Disease)
3.	Ectodermal Dysplasia (Aplasia Cutis Congenita)
4.	Alopecia Areata
5.	Alopecia (Baldness)

Experts

1.	Rogers, Michael A: 2 articles (06/2007 - 01/2006)
2.	Winter, Hermelita: 2 articles (06/2007 - 01/2006)
3.	Langbein, Lutz: 2 articles (06/2007 - 01/2006)
4.	Schweizer, Jürgen: 2 articles (06/2007 - 01/2006)
5.	Trüeb, Ralph M: 1 article (07/2014)
6.	Grimalt, R: 1 article (02/2014)
7.	Moreno-Romero, J A: 1 article (02/2014)
8.	Madnani, Nina: 1 article (09/2013)
9.	Khan, Kaleem: 1 article (09/2013)
10.	Pi, Long-Quan: 1 article (03/2012)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Hair Diseases:

1.	Keratins (Keratin)IBA 04/01/2009 - "Here, we review why a better understanding of the endocrine controls of keratin expression is not only required for an improved insight into normal human skin and hair function, but may also open new therapeutic avenues in a wide range of skin and hair diseases." 08/01/1997 - "Mutations in the hair cortex keratin hHb6 cause the inherited hair disease monilethrix." 06/10/2007 - "Here we provide a detailed description of the respective hair diseases which are either due to mutations in hair keratins (monilethrix, ectodermal dysplasia of hair and nail type) or hair follicle-specific epithelial keratins (two mouse models, RCO3 and Ca(Rin) as well as pseudofolliculitis barbae)."
2.	Minoxidil (Rogaine)FDA LinkGeneric 07/01/2014 - "Retrospective observational study of male and female patients given Erol(®) Energy products in the period between August 2010 and December 2013 at the Center for Dermatology and Hair Diseases Professor Trüeb to treat irritable scalp conditions or as concomitant treatment to minoxidil therapy for androgenetic alocepia. "
3.	CosmeticsIBA 02/01/2014 - "Specific treatment for those hair diseases that do have one, and basic general approach to improve the cosmetic appearance of hair, will be also be discussed for those hair disturbances that do not have a specific treatment. " 09/01/2013 - "Although dermatologists are experts in managing scalp and hair diseases, the esthetic applications of newer cosmetic therapies still remain elusive. " 03/01/2012 - "We expect this approach will be useful for evaluating cellular alteration of natural hairs on cosmetic assessment or diagnosis of hair diseases."
4.	TrichothiodystrophyIBA 12/01/2009 - "Trichothiodystrophy and fragile hair: the distinction between diagnostic signs and diagnostic labels in childhood hair disease." 01/30/1995 - "These are the prototype repair syndrome, xeroderma pigmentosum (XP) (seven genetic complementation groups, designated XP-A to XP-G), Cockayne's syndrome (two groups: CS-A and CS-B) and PIBIDS, a peculiar photosensitive form of the brittle hair disease trichothiodystrophy (TTD, at least two groups of which one equivalent to XP-D). " 09/01/1993 - "In man, a NER defect due to a mutation in one of at least 11 distinct genes, can give rise to the inherited repair disorders xeroderma pigmentosum (XP), Cockayne's syndrome or PIBIDS, a photosensitive form of the brittle hair disease trichothiodystrophy. "
5.	Hair-Specific Keratins (Keratins, Hair Specific)IBA 08/01/1997 - "These mutations provide the first direct evidence for involvement of hair keratins in hair disease." 06/10/2007 - "Here we provide a detailed description of the respective hair diseases which are either due to mutations in hair keratins (monilethrix, ectodermal dysplasia of hair and nail type) or hair follicle-specific epithelial keratins (two mouse models, RCO3 and Ca(Rin) as well as pseudofolliculitis barbae)."
6.	ThalliumIBA 09/01/1954 - "[Local thallium ointment therapy of mycotic hair disease of the skull; preliminary communication]." 04/01/1995 - "[The morphological signs of hair disease in children poisoned by thallium and boron]."
7.	Liposomes (Liposome)IBA 01/01/1998 - "The potential of the hair-follicle liposome delivery system for therapeutic use for hair disease as well as for cosmesis has been demonstrated in 3-dimensional histoculture of hair-growing skin and mouse in vivo models. " 02/01/1997 - "The potential of the hair-follicle liposome delivery system for therapeutic use for hair disease is discussed."
8.	Interleukin-1beta (Interleukin 1 beta)IBA 12/01/1996 - "Moreover, these changes in hair follicle morphology are similar to those reported in alopecia areata and suggest that IL-1 alpha, IL-1 beta and TNF-alpha may play an important part in the pathophysiology of inflammatory hair disease."
9.	Interleukin-1alpha (Interleukin 1 alpha)IBA 12/01/1996 - "Moreover, these changes in hair follicle morphology are similar to those reported in alopecia areata and suggest that IL-1 alpha, IL-1 beta and TNF-alpha may play an important part in the pathophysiology of inflammatory hair disease."
10.	Urea (Carbamide)FDA LinkGeneric 04/01/2002 - "The association with trichorrhexis nodosa, a hair disease sometimes associated with inherited perturbation of metabolism of urea cycle in which visual loss can occur, could suggest an aspecific inhibition of several aminotransferases which could explain different adverse effects of some anti-epileptic drugs (visual abnormalities, alopecia) perhaps in genetic predisposed patients."